J Plaschke1, J Rüschoff, H K Schackert. 1. Department of Surgical Research, Carl Gustav Carus Klinikum, Dresden University of Technology, D-01307 Dresden, Germany. plaschke@rcs.urz.tu-dresden.de
Abstract
BACKGROUND: Germline mutations in mismatch repair genes, mainly in hMLH1, hMSH2, and hMSH6, predispose to the hereditary non-polyposis colorectal cancer (HNPCC) syndrome. A substantial fraction of these mutations exists in genomic rearrangements of hMSH2 and hMLH1. In contrast, genomic rearrangements have not been reported in hMSH6. METHODS: Out of 15 HNPCC or HNPCC-like patients who developed tumours with loss of hMSH6 protein expression, we selected three patients who still had no germline mutations after gene sequencing. Genomic DNA of these patients was analysed using PCR based relative quantification of hMSH6 fragments. Indicated exon deletions and amplifications were characterised by long range PCR and sequencing. RESULTS: Genomic rearrangements were identified in two of the three patients. Breakpoint analyses showed an Alu repeat mediated deletion of 13.0 kb affecting the promoter region, exon 1, and exon 2 in one patient, and a duplication of 4.9 kb containing 1.6 kb of the 3' end of exon 4 and exon 5, integrated into intron 5, in the other patient. CONCLUSIONS: Although genomic rearrangements of hMSH6 only play a small role in the spectrum of all mutations predisposing to HNPCC, our results suggest that up to 10-20% of patients with hMSH6 negative tumours harbour germline rearrangements in this gene.
BACKGROUND: Germline mutations in mismatch repair genes, mainly in hMLH1, hMSH2, and hMSH6, predispose to the hereditary non-polyposis colorectal cancer (HNPCC) syndrome. A substantial fraction of these mutations exists in genomic rearrangements of hMSH2 and hMLH1. In contrast, genomic rearrangements have not been reported in hMSH6. METHODS: Out of 15 HNPCC or HNPCC-like patients who developed tumours with loss of hMSH6 protein expression, we selected three patients who still had no germline mutations after gene sequencing. Genomic DNA of these patients was analysed using PCR based relative quantification of hMSH6 fragments. Indicated exon deletions and amplifications were characterised by long range PCR and sequencing. RESULTS: Genomic rearrangements were identified in two of the three patients. Breakpoint analyses showed an Alu repeat mediated deletion of 13.0 kb affecting the promoter region, exon 1, and exon 2 in one patient, and a duplication of 4.9 kb containing 1.6 kb of the 3' end of exon 4 and exon 5, integrated into intron 5, in the other patient. CONCLUSIONS: Although genomic rearrangements of hMSH6 only play a small role in the spectrum of all mutations predisposing to HNPCC, our results suggest that up to 10-20% of patients with hMSH6 negative tumours harbour germline rearrangements in this gene.
Authors: R C Niessen; M J W Berends; Y Wu; R H Sijmons; H Hollema; M J L Ligtenberg; H E K de Walle; E G E de Vries; A Karrenbeld; C H C M Buys; A G J van der Zee; R M W Hofstra; J H Kleibeuker Journal: Gut Date: 2006-04-24 Impact factor: 23.059
Authors: Bente A Talseth-Palmer; Mary McPhillips; Claire Groombridge; Allan Spigelman; Rodney J Scott Journal: Hered Cancer Clin Pract Date: 2010-05-21 Impact factor: 2.857
Authors: Yanqun Liu; Min Hoe Chew; Xue Wei Goh; Soo Yong Tan; Carol Tien Tau Loi; Yuen Ming Tan; Hai Yang Law; Poh Koon Koh; Choong Leong Tang Journal: PLoS One Date: 2014-04-07 Impact factor: 3.240
Authors: Amy L Masson; Bente A Talseth-Palmer; Tiffany-Jane Evans; Desma M Grice; Garry N Hannan; Rodney J Scott Journal: Hered Cancer Clin Pract Date: 2014-05-24 Impact factor: 2.857
Authors: Sebastian Ribi; Daniel Baumhoer; Kristy Lee; Audrey S M Teo; Babita Madan; Kang Zhang; Wendy K Kohlmann; Fei Yao; Wah Heng Lee; Qiangze Hoi; Shaojiang Cai; Xing Yi Woo; Patrick Tan; Gernot Jundt; Jan Smida; Michaela Nathrath; Wing-Kin Sung; Joshua D Schiffman; David M Virshup; Axel M Hillmer Journal: Oncotarget Date: 2015-04-10